Summary of the Results of Market Surveillance Activities

European legislation on medical devices (MDR) and in vitro diagnostic medical devices (IVDR) requires national authorities to evaluate the effectiveness of their market surveillance activities at least every four years and to publish a public summary of the results (MDR Article 93(8) and IVDR Article 88(8)).

In this context, Denmark hereby presents a summary of the results of the market surveillance activities carried out during the period 2022–2025.

This document provides a concise overview of the key actions, findings, and achievements, as well as the European and national cooperation efforts that support effective market surveillance.

Link

Summary of the Results of Market Surveillance Activities (pdf)